Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, synthesis, structural optimization, SAR, in silico prediction of physicochemical properties and pharmacological evaluation of novel & potent thiazolo[4,5-d]pyrimidine corticotropin releasing factor (CRF) receptor antagonists.
Islam MR, Teleb M, Karageorgos V, Sakellaris S, Papadopoulos M, Pirmettis I, Fronczek FR, Liapakis G, Fahmy H. Islam MR, et al. Among authors: karageorgos v. Eur J Pharm Sci. 2022 Feb 1;169:106084. doi: 10.1016/j.ejps.2021.106084. Epub 2021 Nov 29. Eur J Pharm Sci. 2022. PMID: 34856350 Free article.
Exploring new scaffolds for angiotensin II receptor antagonism.
Kritsi E, Matsoukas MT, Potamitis C, Karageorgos V, Detsi A, Magafa V, Liapakis G, Mavromoustakos T, Zoumpoulakis P. Kritsi E, et al. Among authors: karageorgos v. Bioorg Med Chem. 2016 Sep 15;24(18):4444-4451. doi: 10.1016/j.bmc.2016.07.047. Epub 2016 Jul 22. Bioorg Med Chem. 2016. PMID: 27480029
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferation.
Durdagi S, Aksoydan B, Erol I, Kantarcioglu I, Ergun Y, Bulut G, Acar M, Avsar T, Liapakis G, Karageorgos V, Salmas RE, Sergi B, Alkhatib S, Turan G, Yigit BN, Cantasir K, Kurt B, Kilic T. Durdagi S, et al. Among authors: karageorgos v. Eur J Med Chem. 2018 Feb 10;145:273-290. doi: 10.1016/j.ejmech.2017.12.021. Epub 2017 Dec 11. Eur J Med Chem. 2018. PMID: 29329002
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
Ntountaniotis D, Andreadelis I, Kellici TF, Karageorgos V, Leonis G, Christodoulou E, Kiriakidi S, Becker-Baldus J, Stylos EK, Chatziathanasiadou MV, Chatzigiannis CM, Damalas DE, Aksoydan B, Javornik U, Valsami G, Glaubitz C, Durdagi S, Thomaidis NS, Kolocouris A, Plavec J, Tzakos AG, Liapakis G, Mavromoustakos T. Ntountaniotis D, et al. Among authors: karageorgos v. Mol Pharm. 2019 Mar 4;16(3):1255-1271. doi: 10.1021/acs.molpharmaceut.8b01212. Epub 2019 Feb 13. Mol Pharm. 2019. PMID: 30681344
Selective antagonism of CRF1 receptor by a substituted pyrimidine.
Sakellaris S, Matsoukas MT, Karageorgos V, Poulaki S, Kuppast B, Margioris A, Venihaki M, Fahmy H, Liapakis G. Sakellaris S, et al. Among authors: karageorgos v. Hormones (Athens). 2019 Jun;18(2):215-221. doi: 10.1007/s42000-019-00105-9. Epub 2019 Apr 12. Hormones (Athens). 2019. PMID: 30980254
Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.
Liapakis G, Karageorgos V, Andreadelis I, Holz GG, Dermitzaki E, Kordopati GG, Stylos EΚ, Spyridaki K, Poulaki S, Ntountaniotis D, Sakellaris S, Vanioti M, Kostagianni A, Marousis KD, Leonis G, Kokotos G, Venihaki M, Spyroulias GA, Tselios T, Margioris A, Tzakos AG, Mavromoustakos T. Liapakis G, et al. Among authors: karageorgos v. Amino Acids. 2020 Sep;52(9):1337-1351. doi: 10.1007/s00726-020-02895-4. Epub 2020 Sep 29. Amino Acids. 2020. PMID: 32996057 Free PMC article.
Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonists.
Elgiushy HR, Abou-Taleb NA, Holz GG, Chepurny OG, Pirmettis I, Kakabakos S, Karageorgos V, Liapakis G, Albohy A, Abouzid KAM, Hammad SF. Elgiushy HR, et al. Among authors: karageorgos v. Bioorg Chem. 2021 Sep;114:105079. doi: 10.1016/j.bioorg.2021.105079. Epub 2021 Jun 10. Bioorg Chem. 2021. PMID: 34174633 Free PMC article.
20 results